{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:03:23Z","timestamp":1782601403972,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaut.2014.05.004","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T10:48:48Z","timestamp":1408013328000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["NMO spectrum of disorders: A paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases"],"prefix":"10.1016","volume":"54","author":[{"given":"Adi","family":"Vaknin-Dembinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrius","family":"Karussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Avichzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Abramsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.05.004_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.004_bib3","first-page":"1","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib4","first-page":"1891","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A\u00a0population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.004_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2009.08.045","article-title":"Neuromyelitis optica: effect of gender","volume":"286","author":"Wingerchuk","year":"2009","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jaut.2014.05.004_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archneurol.2011.200","article-title":"Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?","volume":"68","author":"Vaknin-Dembinsky","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib9","first-page":"2097","article-title":"Two cases of benign neuromyelitis optica in patients with celiac disease","volume":"256","author":"Bergamaschi","year":"2009","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458511431728","article-title":"Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature","volume":"18","author":"Jarius","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.05.004_bib11","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","article-title":"Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution","volume":"80","author":"Matthews","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.004_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1352458510382685","article-title":"Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica","volume":"17","author":"Lim","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.05.004_bib13","doi-asserted-by":"crossref","unstructured":"Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K, et\u00a0al. Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci;320:32\u201337.","DOI":"10.1016\/j.jns.2012.06.002"},{"key":"10.1016\/j.jaut.2014.05.004_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","article-title":"Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders","volume":"84","author":"Jacob","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jaut.2014.05.004_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ana.22121","article-title":"Intractable vomiting as the initial presentation of neuromyelitis optica","volume":"68","author":"Apiwattanakul","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318214332c","article-title":"Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications","volume":"76","author":"Popescu","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.004_bib17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archneurol.2009.264","article-title":"Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications","volume":"66","author":"Kanbayashi","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A\u00a0role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","article-title":"Neuromyelitis optica","volume":"10","author":"Wingerchuk","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1352458508100837","article-title":"Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder","volume":"15","author":"Bonnan","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.05.004_bib22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/1352458511432896","article-title":"Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success","volume":"18","author":"Greenberg","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.05.004_bib23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archneurol.2010.322","article-title":"Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica","volume":"68","author":"Kim","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib25","first-page":"1919","article-title":"Natalizumab and the development of extensive brain lesions in neuromyelitis optica","volume":"260","author":"Jurynczyk","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib26","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1177\/1352458512439439","article-title":"Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?","volume":"18","author":"Kim","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.05.004_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nrm1469","article-title":"From structure to disease: the evolving tale of aquaporin biology","volume":"5","author":"King","year":"2004","journal-title":"Nat Rev Mol Cell biol"},{"key":"10.1016\/j.jaut.2014.05.004_bib28","doi-asserted-by":"crossref","unstructured":"Iorio R, Fryer JP, Hinson SR, Fallier-Becker P, Wolburg H, Pittock SJ, et\u00a0al. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun;40:21\u201327.","DOI":"10.1016\/j.jaut.2012.07.008"},{"key":"10.1016\/j.jaut.2014.05.004_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12031-008-9057-7","article-title":"Brain-region-specific astroglial responses in\u00a0vitro after LPS exposure","volume":"35","author":"Kipp","year":"2008","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.jaut.2014.05.004_bib30","doi-asserted-by":"crossref","first-page":"320519","DOI":"10.1155\/2013\/320519","article-title":"Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation","volume":"2013","author":"Gimsa","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaut.2014.05.004_bib31","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.1206936","article-title":"The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence","volume":"334","author":"Alvarez","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.05.004_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/(SICI)1098-1136(199703)19:3<190::AID-GLIA2>3.0.CO;2-3","article-title":"Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta","volume":"19","author":"Vincent","year":"1997","journal-title":"Glia"},{"issue":"Pt 2","key":"10.1016\/j.jaut.2014.05.004_bib33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/brain\/119.2.651","article-title":"Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in\u00a0vivo","volume":"119","author":"Gold","year":"1996","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1098-1136(200010)32:1<25::AID-GLIA30>3.0.CO;2-Y","article-title":"Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration","volume":"32","author":"Bechmann","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.jaut.2014.05.004_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2013.10.012","article-title":"Astrocyte loss and astrogliosis in neuroinflammatory disorders","volume":"565C","author":"Hostenbach","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jaut.2014.05.004_bib36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/glia.22635","article-title":"Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures","volume":"62","author":"Howe","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.jaut.2014.05.004_bib37","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","article-title":"Genomic analysis of reactive astrogliosis","volume":"32","author":"Zamanian","year":"2012","journal-title":"J\u00a0Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.jaut.2014.05.004_bib38","doi-asserted-by":"crossref","first-page":"e61835","DOI":"10.1371\/journal.pone.0061835","article-title":"Characteristic cerebrospinal fluid cytokine\/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis","volume":"8","author":"Matsushita","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.jaut.2014.05.004_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.0b013e3181e2414b","article-title":"Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study","volume":"75","author":"Takano","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.004_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bpa.12098","article-title":"Experimental models of neuromyelitis optica","volume":"24","author":"Bradl","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jaut.2014.05.004_bib41","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1073\/pnas.85.24.9724","article-title":"Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1","volume":"85","author":"Teitelbaum","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.004_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in\u00a0vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaut.2014.05.004_bib45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex\u00a0vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib46","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","article-title":"Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2","volume":"205","author":"Hinson","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.004_bib47","first-page":"349","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain","volume":"133","author":"Saadoun","year":"2010","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2014.05.004_bib48","doi-asserted-by":"crossref","unstructured":"Saadoun S, Waters P, Macdonald C, Bridges LR, Bell BA, Vincent A, et\u00a0al. T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement. J Neuroimmunol;235:27\u201332.","DOI":"10.1016\/j.jneuroim.2011.03.007"},{"key":"10.1016\/j.jaut.2014.05.004_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","article-title":"Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59","volume":"53","author":"Zhang","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.004_bib50","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature06559","article-title":"Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets","volume":"451","author":"Han","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.05.004_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1110740","article-title":"Potassium channel KIR4.1 as an immune target in multiple sclerosis","volume":"367","author":"Srivastava","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2014.05.004_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.22443","article-title":"The astrocyte in multiple sclerosis revisited","volume":"61","author":"Brosnan","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.jaut.2014.05.004_bib53","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/glia.22414","article-title":"Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model","volume":"60","author":"Bataveljic","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.jaut.2014.05.004_bib54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.56.10.1257","article-title":"ADEM: distinct disease or part of the MS spectrum?","volume":"56","author":"Hartung","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.004_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1212\/WNL.0000000000000097","article-title":"Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease","volume":"82","author":"Kraus","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.004_bib56","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/1352458511400475","article-title":"Astrocytopathy in Balo's disease","volume":"17","author":"Kira","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.05.004_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2011.08.043","article-title":"Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders","volume":"311","author":"Kira","year":"2011","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jaut.2014.05.004_bib58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2012.05.004","article-title":"Pierre Youinou: when intuition and determination meet autoimmunity","volume":"39","author":"Jamin","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.004_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.07.006","article-title":"Abul Abbas: an epitope of scholarship","volume":"45","author":"Gershwin","year":"2013","journal-title":"J\u00a0Autoimmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:12:06Z","timestamp":1760256726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":59,"alternative-id":["S0896841114000936"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.05.004","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMO spectrum of disorders: A paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}